Dr John Joseph Kirkowski, DO - Medicare Family Medicine in Canton, PA

Dr John Joseph Kirkowski, DO is a medicare enrolled "Family Medicine" physician in Canton, Pennsylvania. His current practice location is 127 Sullivan St, Canton, Pennsylvania. You can reach out to his office (for appointments etc.) via phone at (570) 673-3197.

Dr John Joseph Kirkowski is licensed to practice in Pennsylvania (license number OS003118L) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1558476648.

Contact Information

Dr John Joseph Kirkowski, DO
127 Sullivan St,
Canton, PA 17724-1733
(570) 673-3197
(570) 673-8297



Physician's Profile

Full NameDr John Joseph Kirkowski
GenderMale
SpecialityFamily Medicine
Location127 Sullivan St, Canton, Pennsylvania
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1558476648
  • Provider Enumeration Date: 08/20/2006
  • Last Update Date: 06/09/2015
  Medicare PECOS Information:
  • PECOS PAC ID: 0345296794
  • Enrollment ID: I20050329000518

Medical Identifiers

Medical identifiers for Dr John Joseph Kirkowski such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1558476648NPI-NPPES
101235309MedicaidPA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine OS003118L (Pennsylvania)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr John Joseph Kirkowski allows following entities to bill medicare on his behalf.
Entity NameGuthrie Medical Group Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1962451153
PECOS PAC ID: 6002728656
Enrollment ID: O20040301000571

News Archive

Researchers identify cannabinoid-making pathway

U of S researchers have discovered the chemical pathway that Cannabis sativa uses to create bioactive compounds called cannabinoids, paving the way for the development of marijuana varieties to produce pharmaceuticals or cannabinoid-free industrial hemp.

PBS NewsHour examines family planning in the Philippines

PBS NewsHour on Monday aired the second installment in its "Food for 9 Billion" series, in which "Sam Eaton of Homelands Productions goes to the fishing village of Humay-Humay" in the Philippines and "speaks with families about their concerns that future generations won't enjoy the same access to fish as a food staple and way of life," the PBS NewsHour blog "The Rundown" reports.

D614G mutation in SARS-CoV-2 increases viral fitness and infectivity

Researchers from the Duke Human Vaccine Institute and Duke University, Durham NC, USA, recently analyzed the D614G mutation in SARS-CoV-2 in the context of a soluble S ectodomain construct. Their study has been published in the preprint server bioRxiv.

Allergan's investigational medication rapastinel granted FDA Breakthrough Therapy designation

Allergan plc., a leading global pharmaceutical company today announced that its Phase III ready investigational medication rapastinel (GLYX-13) received Breakthrough Therapy designation from the U.S. Food and Drug Administration for adjunctive treatment of Major Depressive Disorder (MDD).

New study finds SARS-CoV-2 causes retinal infection

Can coronavirus disease 2019 (COVID-19) affect the eye? New research suggests the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can enter the eye and infect photoreceptor and retinal ganglion cells. In addition, SARS-CoV-2 infection increases the expression of several inflammatory genes, including the cytokine interleukin 33 (IL33), which is linked to COVID-19 disease and retinal degeneration.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr John Joseph Kirkowski is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr John Joseph Kirkowski, DO
1 Guthrie Sq,
Sayre, PA 18840-1625

Ph: (570) 888-5858
Dr John Joseph Kirkowski, DO
127 Sullivan St,
Canton, PA 17724-1733

Ph: (570) 673-3197

News Archive

Researchers identify cannabinoid-making pathway

U of S researchers have discovered the chemical pathway that Cannabis sativa uses to create bioactive compounds called cannabinoids, paving the way for the development of marijuana varieties to produce pharmaceuticals or cannabinoid-free industrial hemp.

PBS NewsHour examines family planning in the Philippines

PBS NewsHour on Monday aired the second installment in its "Food for 9 Billion" series, in which "Sam Eaton of Homelands Productions goes to the fishing village of Humay-Humay" in the Philippines and "speaks with families about their concerns that future generations won't enjoy the same access to fish as a food staple and way of life," the PBS NewsHour blog "The Rundown" reports.

D614G mutation in SARS-CoV-2 increases viral fitness and infectivity

Researchers from the Duke Human Vaccine Institute and Duke University, Durham NC, USA, recently analyzed the D614G mutation in SARS-CoV-2 in the context of a soluble S ectodomain construct. Their study has been published in the preprint server bioRxiv.

Allergan's investigational medication rapastinel granted FDA Breakthrough Therapy designation

Allergan plc., a leading global pharmaceutical company today announced that its Phase III ready investigational medication rapastinel (GLYX-13) received Breakthrough Therapy designation from the U.S. Food and Drug Administration for adjunctive treatment of Major Depressive Disorder (MDD).

New study finds SARS-CoV-2 causes retinal infection

Can coronavirus disease 2019 (COVID-19) affect the eye? New research suggests the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can enter the eye and infect photoreceptor and retinal ganglion cells. In addition, SARS-CoV-2 infection increases the expression of several inflammatory genes, including the cytokine interleukin 33 (IL33), which is linked to COVID-19 disease and retinal degeneration.

Read more News

› Verified 9 days ago


Family Medicine Doctors in Canton, PA

Dr. John Harold Weis, DO
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 61 Sullivan St, Canton, PA 17724
Phone: 570-673-3197    Fax: 570-673-8297

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.